The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity

Blood

Volumn 96, Issue 7, 2000, Pages 2469-2478

  Frenette, Paul S ^a   Weiss, Linnea ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRINOGEN RECEPTOR; GLYCOCALICIN; GLYCOPROTEIN IB; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBIN RECEPTOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; HEMOSTASIS; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0034307532     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.7.2469.h8002469_2469_2478     Document Type: Article

References (73)

1. Molecular abnormalities in Glanzmann's thrombasthenia, Bernard-Soulier syndrome, and platelet-type von Willebrand's disease
2. Specific synergy of multiple substrate-receptor interactions in platelel thrombus formation under flow
3. A revised model of platelet aggregation
4. Cloning of the alpha chain of human platelet glycoprotein Ib: A transmembrane protein with homology to leucine-rich alpha 2-glycoprotein
5. The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence
6. Human platelet glycoprotein IX: An adhesive prototype of leucine-rich glycoproteins with flank-center-flank structures
7. Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation
8. Platelet GPIb-V-IX complex. Structure, function, physiology, and pathology
9. Von Willebrand factor binding to platelet GPIb initiates signals for platelel activation
10. Adhesion receptor activation of phosphatidylinositol 3-kinase. Von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60(c-src) in human platelets
11. Glycoprotein Ib-von Willebrand factor interactions activate tyrosine kinases in human platelets
12. The platelet antigens CD9, CD42 and integrin alpha IIb beta IIIa can be topographically associated and transduce functionally similar signals
13. The von Willebrand factor-glycopretein Ib/V/IX interaction induces actin polymerization and cytoskeletal reorganization in rolling platelets and glycoprotein Ib/V/IX-transfected cells
14. Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface
15. Localization of a thrombin-binding site on human platelet membrane glycoprotein Ib determined by a monoclonal antibody
16. 2+] induced by alpha-thrombin
17. Function of glycoprotein Iba in platelet activation induced by α-thrombin
18. Localization and characterization of an α-thrombin-binding site on platelet glycoprotein Ibα
19. Characterization of a functional thrombin receptor: Issues and opportunities
20. Binding of thrombin to the G-protein-linked receptor, and not to glycoprotein Ib, precedes thrombin-mediated platelet activation
21. Activation of platelets by alpha-thrombin is a receptor-mediated event. D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone-thrombin, but not N alpha-tosyl-L-lysine chloromethyl ketone-thrombin, binds to the high affinity thrombin receptor
22. Pathophysiology of platelet thrombin receptors
23. Thrombin interaction with platelet glycoprotein Ib: Effect of glycocalicin on thrombin specificity
24. Identification of three tyrosine residues of glycoprotein Ib alpha with distinct roles in von Willebrand factor and alpha-thrombin binding
25. Cloning and characterization of human protease-activated receptor 4
26. A dual thrombin receptor system for platelet activation
27. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
28. Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation
29. Platelet prothrombin converting activity in hereditary disorders of platelet function
30. Impaired prothrombin consumption in Bernard-Soulier syndrome is corrected in vitro by human factor VIII
31. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets
32. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets
33. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation; a flow cytometry study showing a role for free sulfhydryl groups
34. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platetet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity
35. Role of caspase in a subset of human platelet activation responses
36. Thrombin interaction with platelet GPIb: Role of the heparin binding domain
37. Characteristics of the interaction between thrombin exosite 1 and the sequence 269-297 of platelet glycoprotein Ibα
38. Binding of human alpha-thrombin to platelet GpIb: Energetics and functional effects
39. Binding of heparin to platelet membrane glycoprotein Ib: Functional effects
40. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor
41. The platelet high affinity binding site for thrombin mimics hirudin, modulates thrombin-induced platelet activation, and is distinct from the glycoprotein Ib-IX-V complex
42. 2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide
43. Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex
44. The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin
45. Ultra-rapid fluorescent labelling of proteins
46. Glyco-protein VI is a major collagen receptor for platelet activation: It recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not
47. Isolation of human platelets by albumin gradient and gel filtration
48. Thrombin receptor activating peptide does not stimulate platelet procoagulant activity
49. Differential mobilization of tyrosine kinases in human platelets stimulated with thrombin or thrombin receptor agonist peptide
50. Different abilities of thrombin receptor activating peptide and thrombin to induce platelet calcium rise and full release reaction
51. 2 synthesis
52. Platelet glycocalicin: A single receptor for platelet aggregation induced by thrombin or ristocetin
53. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
54. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin
55. Interaction of echicetin with a high affinity thrombin binding site on platelet glycoprotein GPIb
56. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib
57. Reduced thrombin binding and aggregation in Bernard-Soulier platelets
58. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function
59. 3 (platelet GPIIb-IIIa)
60. Arg-Gly-Asp: A versatile cell recognition signal
61. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa
62. 3 binds prothrombin and influences its activation
63. Thrombin-induced platelet activation is inhibited by high-and low-molecular-weight heparin
64. Multiple active forms of thrombin: Binding to platelets and effects on platelet function
65. Cross-linking of α- and γ/-thrombin to distinct binding sites on human platelets
66. Expressed full-length von Willebrand factor containing missense mutations linked to type IIb von Willebrand disease shows enhanced binding to platelets
67. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction
68. Thrombin interaction with platelet GpIb: Structural mapping and effects on platelet activation
69. Tyrosine sulfation of the glycoprotein Ib-IX complex: Identification of sulfated residues and effect on ligand binding
70. Requirement of leucine-rich repeats of glycoprotein (GP) Ibα for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex
71. Platelet shape change induced by thrombin receptor activation: Rapid stimulation of tyrosine phosphorylation of novel protein substrates through an integrin- and Ca(2+)-independent mechanism
72. Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation
73. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity